Advertisement.

ORXOF Projected Dividend Yield

Orexo AB ( OTCBB : ORXOF )

Orexo is an integrated pharma company with commercial operations in the U.S. and research and development in Sweden. Co.'s focus is primarily on opioid dependence and pain. Co.'s product portfolio includes Zubsolv®, a product for the treatment of opioid dependence; Abstral®, a sublingual tablet for the treatment of breakthrough cancer pain in patients; and Edluar®, for the treatment of short-term insomnia. Co.'s development projects include OX124 and OX125, both for treatment of opiod overdose; OX338 to treat moderate to moderately severe pain; and OX-MPI, to treat microvascular disease.

21 YEAR PERFORMANCE RESULTS

ORXOF Dividend History Detail
ORXOF Dividend News
ORXOF Competitors News

# of Shares: 0

Closing Price: 1.08

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000